{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:06:47Z","timestamp":1793232407982,"version":"4.5.0"},"reference-count":55,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,9,17]]},"published-print":{"date-parts":[[2026,1]]},"DOI":"10.2967\/jnumed.125.269818","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:25:12Z","timestamp":1761229512000},"page":"85-91","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of [\n                    <sup>18<\/sup>\n                    F]PSMA-1007 PET\/CT in Primary Staging of Prostate Carcinoma: A Systematic Review and Metaanalysis"],"prefix":"10.2967","volume":"67","author":[{"given":"Kambiz","family":"Rahbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik L.","family":"Giesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hoepping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2026010206300905000_67.1.85.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2026010206300905000_67.1.85.2","doi-asserted-by":"crossref","unstructured":"Sekhoacha M Riet K Motloung P Gumenku L Adegoke A Mashele S . Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27:5730.","DOI":"10.3390\/molecules27175730"},{"key":"2026010206300905000_67.1.85.3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer: 2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol."},{"key":"2026010206300905000_67.1.85.4","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003492"},{"key":"2026010206300905000_67.1.85.5","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001497"},{"key":"2026010206300905000_67.1.85.6","doi-asserted-by":"crossref","unstructured":"Brierley JD Gospodarowicz MK Wittekind C . TNM Classification of Malignant Tumours. 8th ed. Union for International Cancer Control; 2016:191\u2013195.","DOI":"10.1002\/9780471420194.tnmc41.pub3"},{"key":"2026010206300905000_67.1.85.7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21391"},{"key":"2026010206300905000_67.1.85.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.12.018"},{"key":"2026010206300905000_67.1.85.9","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300905000_67.1.85.10","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S"},{"key":"2026010206300905000_67.1.85.11","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-008-9104-2"},{"key":"2026010206300905000_67.1.85.12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prnil.2022.03.003","article-title":"Diagnostic value of integrated 18F-PSMA-1007 PET\/MRI compared with that of biparametric MRI for the detection of prostate cancer","volume":"10","author":"Zeng","year":"2022","journal-title":"Prostate Int."},{"key":"2026010206300905000_67.1.85.13","doi-asserted-by":"crossref","unstructured":"Maisto C Aurilio M Morisco A . Analysis of pros and cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: production, costs, and PET\/CT applications in patients with prostate cancer. Molecules. 2022;27:3962.","DOI":"10.3390\/molecules27123862"},{"key":"2026010206300905000_67.1.85.14","first-page":"40","article-title":"meta: an R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R News."},{"key":"2026010206300905000_67.1.85.15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13550-020-00730-1","article-title":"The value of 18F-PSMA-1007 PET\/CT in identifying non-metastatic high-risk prostate cancer","volume":"10","author":"Hong","year":"2020","journal-title":"EJNMMI Res."},{"key":"2026010206300905000_67.1.85.16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40644-023-00627-x","article-title":"Evaluating the value of 18F-PSMA-1007 PET\/CT in the detection and identification of prostate cancer using histopathology as the standard","volume":"23","author":"Luo","year":"2023","journal-title":"Cancer Imaging."},{"key":"2026010206300905000_67.1.85.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234187"},{"key":"2026010206300905000_67.1.85.18","doi-asserted-by":"crossref","unstructured":"Hoffmann MA Muller-Hubenthal J Rosar F . Primary staging of prostate cancer patients with [18F]PSMA-1007 PET\/CT compared with [68Ga]Ga-PSMA-11 PET\/CT. J Clin Med. 2022:11:5064.","DOI":"10.3390\/jcm11175064"},{"key":"2026010206300905000_67.1.85.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.189233"},{"key":"2026010206300905000_67.1.85.20","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1038\/s41598-021-85028-5","article-title":"The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer","volume":"11","author":"Zamboglou","year":"2021","journal-title":"Sci Rep."},{"key":"2026010206300905000_67.1.85.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-020-00292-2"},{"key":"2026010206300905000_67.1.85.22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00345-023-04345-8","article-title":"Status of 18F-PSMA-1007-PET\/CT compared with multiparametric MRI in preoperative evaluation of prostate cancer","volume":"41","author":"Tang","year":"2023","journal-title":"World J Urol."},{"key":"2026010206300905000_67.1.85.23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.euo.2023.04.006","article-title":"Head-to-head comparison of 18F-PSMA-1007 positron emission tomography\/computed tomography and multiparametric magnetic resonance imaging with whole-mount histopathology as reference in localisation and staging of primary prostate cancer","volume":"6","author":"Exterkate","year":"2023","journal-title":"Eur Urol Oncol."},{"key":"2026010206300905000_67.1.85.24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jamaoncol.2024.3196","article-title":"Fluorine-18 prostate-specific membrane antigen-1007 PET\/CT vs multiparametric MRI for locoregional staging of prostate cancer","volume":"10","author":"Mookerji","year":"2024","journal-title":"JAMA. Oncol."},{"key":"2026010206300905000_67.1.85.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3573-4"},{"key":"2026010206300905000_67.1.85.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.246363"},{"key":"2026010206300905000_67.1.85.27","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1007\/s00259-022-05827-4","article-title":"Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron emission tomography\/computed tomography in newly diagnosed intermediate- to high-risk prostate cancer using histopathological evaluation of extended pelvic node dissection as reference","volume":"49","author":"Hermsen","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300905000_67.1.85.28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13550-022-00918-7","article-title":"Assessing the accuracy of [18F]PSMA-1007 PET\/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients","volume":"12","author":"Ingvar","year":"2022","journal-title":"EJNMMI Res."},{"key":"2026010206300905000_67.1.85.29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41391-021-00452-y","article-title":"Preoperative PSMA-PET\/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection","volume":"25","author":"Baas","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2026010206300905000_67.1.85.30","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00259-021-05296-1","article-title":"Prospective comparison of 18F-PSMA-1007 PET\/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer","volume":"48","author":"Malaspina","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300905000_67.1.85.31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.euo.2020.06.012","article-title":"A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with diffusion-weighted imaging, and single-photon emission computed tomography\/computed tomography with traditional imaging in primary distant metastasis staging of prostate cancer (PROSTAGE)","volume":"4","author":"Anttinen","year":"2021","journal-title":"Eur Urol Oncol."},{"key":"2026010206300905000_67.1.85.32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/bjr\/tqae021","article-title":"Clinical value of 18F-PSMA-1007 PET\/MRI in primary staging of patients with intermediate- to high-risk prostate cancer","volume":"97","author":"Ali","year":"2024","journal-title":"Br J Radiol."},{"key":"2026010206300905000_67.1.85.33","doi-asserted-by":"crossref","unstructured":"Awenat S Piccardo A Carvoeiras P . Diagnostic role of 18F-PSMA-1007 PET\/CT in prostate cancer staging: a systematic review. Diagnostics (Basel). 2021;11:552.","DOI":"10.3390\/diagnostics11030552"},{"key":"2026010206300905000_67.1.85.34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018180788"},{"key":"2026010206300905000_67.1.85.35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1148\/radiol.2019190687","article-title":"Diagnostic accuracy of multiparametric MRI versus 68Ga-PSMA-11 PET\/MRI for extracapsular extension and seminal vesicle invasion in patients with prostate cancer","volume":"293","author":"Muehlematter","year":"2019","journal-title":"Radiology."},{"key":"2026010206300905000_67.1.85.36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.207696"},{"key":"2026010206300905000_67.1.85.37","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264743"},{"key":"2026010206300905000_67.1.85.38","unstructured":"Summary of Product Characteristics [Radelumin 2000 MBq\/mL solution for injection]. ABX; March 2023."},{"key":"2026010206300905000_67.1.85.39","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2026010206300905000_67.1.85.40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"key":"2026010206300905000_67.1.85.41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol."},{"key":"2026010206300905000_67.1.85.42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5301\/uro.5000139","article-title":"Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches","volume":"84","author":"Bianchi","year":"2017","journal-title":"Urologia."},{"key":"2026010206300905000_67.1.85.43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/JU.0000000000000504","article-title":"Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D\u2019Amico intermediate and high risk prostate cancer treated with radical prostatectomy: a multi-institutional study","volume":"203","author":"Preisser","year":"2020","journal-title":"J Urol."},{"key":"2026010206300905000_67.1.85.44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000497280","article-title":"Reconsideration on clinical benefit of pelvic lymph node dissection during radical prostatectomy for clinically localized prostate cancer","volume":"103","author":"Fujimoto","year":"2019","journal-title":"Urol Int."},{"key":"2026010206300905000_67.1.85.45","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1007\/s00259-024-06797-5","article-title":"The homunculus of unspecific bone uptakes associated with PSMA-targeted tracers: a systematic review-based definition","volume":"51","author":"Rizzo","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300905000_67.1.85.46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.semnuclmed.2023.11.001","article-title":"A practical guide to the pearls and pitfalls of PSMA PET imaging","volume":"54","author":"Voter","year":"2024","journal-title":"Semin Nucl Med."},{"key":"2026010206300905000_67.1.85.47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00259-023-06424-9","article-title":"The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake","volume":"51","author":"Ninatti","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300905000_67.1.85.48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.euo.2022.03.004","article-title":"[68Ga]Ga-PSMA versus [18F]PSMA positron emission tomography\/computed tomography in the staging of primary and recurrent prostate cancer. A systematic review of the literature","volume":"5","author":"Evangelista","year":"2022","journal-title":"Eur Urol Oncol."},{"key":"2026010206300905000_67.1.85.49","doi-asserted-by":"crossref","first-page":"1025930","DOI":"10.3389\/fonc.2022.1025930","article-title":"18F-PSMA-1007 PET\/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer","volume":"12","author":"Dong","year":"2022","journal-title":"Front Oncol."},{"key":"2026010206300905000_67.1.85.50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JU.0000000000004025","article-title":"Radical prostatectomy without prior biopsy in selected patients evaluated by 18F-labeled prostate-specific membrane antigen\u2013ligand positron emission tomography\/computed tomography and multiparameter magnetic resonance imaging: a single-center, prospective, single-arm trial","volume":"212","author":"Niu","year":"2024","journal-title":"J Urol."},{"key":"2026010206300905000_67.1.85.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.08.004"},{"key":"2026010206300905000_67.1.85.52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JU.0000000000002497","article-title":"The effect of different types of prostate biopsy techniques on post-biopsy infectious complications","volume":"208","author":"Tops","year":"2022","journal-title":"J Urol."},{"key":"2026010206300905000_67.1.85.53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00345-016-1893-4","article-title":"Can robot-assisted laparoscopic radical prostatectomy (RALP) be performed very soon after biopsy?","volume":"35","author":"Jo","year":"2017","journal-title":"World J Urol."},{"key":"2026010206300905000_67.1.85.54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MOU.0000000000000510","article-title":"Prostate biopsy","volume":"28","author":"H\u00fcbner","year":"2018","journal-title":"Curr Opin Urol."},{"key":"2026010206300905000_67.1.85.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910038"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.269818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T14:30:37Z","timestamp":1767364237000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.269818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.2967\/jnumed.125.269818"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.269818","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}